Pricing Log in Create free account
Saturday 31 October 2026 Export AZN’s income statement to Excel — free account

AstraZeneca PLC

AZN Healthcare Drug Manufacturers General

AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024. In the quarter to June 2026, revenue grew 6.41%, EPS grew 1.90%, free cash flow fell 107.5% and total debt fell 5.50%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five; insiders bought in the last twelve months.

186.38 11.98 +6.87%
Market cap
$270.5B
P/E
27.6×
Fwd P/E
22.4×
Dividend yield
1.72%
F-score
9/9
Altman Z
3.52
Beneish M
−2.51
Dividend safety
54/100
Overview Business Profile Financial Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

AstraZeneca PLC (AZN) P/E ratio

Alert me on P/E ratio

As of 30 October 2026, AstraZeneca PLC (AZN) trades at a P/E ratio of 27.6×. Over the past ten years it has ranged from 0.0× (September 2022) to 454× (March 2022); the current reading is higher than 23% of that period. That is in line with the Drug Manufacturers General industry median of 27.6× and above the Healthcare sector median of 25.8×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 26.6× (7.01%)
FY2024 28.6× (16.91%)
FY2023 34.4× (46.03%)
FY2022 63.8× (83.49%)
FY2021 386× 840.56%
FY2020 41.1× (56.91%)
FY2019 95.3× 113.25%
FY2018 44.7× 55.04%
FY2017 28.8× 44.56%
FY2016 19.9× (33.65%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 28.1× (4.28%)
Mar 2026 29.4× 10.53%
Dec 2025 26.6× 7.89%
Sep 2025 24.6× (5.73%)
42 more quarters

Against its own ten years

Low 0.0× High 454×
Ten-year median 35.7×
Current reading's percentile 22

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S compare 9.8×
BMY Bristol Myers Squibb Company compare 13.8×
NVS Novartis AG compare 24.1×
AZN AstraZeneca PLC 27.6×
AMGN Amgen Inc. compare 28.7×
PFE Pfizer Inc. compare 40.1×
ABBV AbbVie Inc. compare 83.3×
MRK Merck & Co., Inc. compare 120×
Drug Manufacturers General industry median 27.6×
Healthcare sector median 25.8×
Market median 18.6×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on AZN